{'fraction_non_alphanumeric': 0.03142268934879185, 'fraction_numerical': 0.013977679055152237, 'mean_word_length': 5.361130254996554, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 1, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Primary biphasic synovial sarcoma of the lung: A case report

Introduction: Primary synovial sarcoma of the lung is an extremely rare tumor, accounting for less than 0.5% of all lung tumors. The diagnosis is established only after sarcomalike primary lung malignancies and metastatic sarcoma have been excluded. Case Report: A 70-year-old female patient was admitted to our hospital because of a right lower lobe lung mass. Computed tomography-guided needle biopsy revealed the presence of spindle cell sarcoma. The patient underwent right lower lobectomy and combined resection of the pericardium. Histologically, the tumor displayed tubular proliferation of epithelial cells and fascicular proliferation of spindle cells. Immunohistochemically, both tumor cell types were positive for vimentin and bcl-2. Pleomorphic carcinoma or synovial sarcoma was suggested as a diagnosis. We found the presence of SYT-SSX fusion gene transcripts in RNA samples from frozen tissue from the tumor. The final diagnosis was primary pulmonary biphasic synovial sarcoma. Conclusion: We report an extremely rare case of primary Hiroshi Hashimoto1, Yuichi Ozeki1, Koji Kameda1, Hideyuki Shimazaki2, Kuniaki Nakanishi2, Shinichi Taguchi1 Affiliations: 1Department of Thoracic Surgery, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, Japan; 2Department of Pathology and Laboratory Medicine, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, Japan. Corresponding Author: Hiroshi Hashimoto, Department of Thoracic Surgery, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama 359-8513, Japan; Email: hashimoh@ndmc.ac.jp Received: 07 June 2018 Accepted: 28 June 2018 Published: 18 July 2018 pulmonary biphasic synovial sarcoma. Our findings indicate that molecular detection of SYT-SSX fusion gene transcripts is very helpful and may be necessary when synovial sarcoma is recognized at uncommon sites.


INTRODUCTION
Synovial sarcoma is a morphologically well-defined neoplasm that most commonly occurs in soft tissues of the extremities [1]. This type of tumor accounts for ~10% of all soft tissue sarcomas. Also this tumor has been described in numerous locations, including the head and neck, chest and abdominal wall. Primary synovial sarcoma of the lung is extremely rare and accounts for less than 0.5% of all lung tumor [2]. Here we report the case of a 70-year-old female patient who presented with a large right lower lobe lung mass lesion. The patient was subsequently diagnosed with primary biphasic synovial sarcoma of the lung and the tumor was completely resected surgically.

CASE REPORT
A 70-year-old female patient presented with an incidentally found mass in the right lung. The mass was detected on a chest X-ray during a regular medical checkup ( Figure 1). The patient was a non-smoker with no history of asbestos exposure. Physical and neurological examinations were unremarkable. The results of blood tests and standard biochemical tests were normal. Arterial blood gas analysis and tumor marker results were also normal.
A computed tomography (CT) scan of the chest revealed a 5 cm well-defined mass occupying the right lower lobe (Figure 2). CT-guided needle biopsy revealed the presence of spindle cell sarcoma. The tumor had rapidly enlarged in a short period after the needle biopsy. Since there was no evidence of distant metastasis, the patient underwent thoracotomy.
The tumor had directly invaded the pericardium and was adherent to the middle lobe ( Figure 3). A right lower lobectomy with combined resection of the pericardium and radical lymph node dissection was performed. The postoperative course was uneventful and the patient was discharged on postoperative day 16.
Histopathological examination of the tumor revealed that it was a well-circumscribed, round tumor, 65×45 ×75 mm in size. The tumor had extensive macroscopic necrosis ( Figure 4) and displayed tubular proliferation of epithelial cells and fascicular proliferation of spindle cells in a biphasic pattern ( Figure 5). Although there was infiltration of the tumor into the pericardium, all surgical margins were tumor-free and the lymph nodes were not involved. Immunohistochemically, both epithelial cells and spindle cells were positive for vimentin and bcl-2, but negative for thyroid transcription factor-1, napsin A, CD34, CD117, demin, S-100, h-caldesmon, and anaplastic lymphoma kinase ( Figure 6). We found SYT-SSX fusion gene transcripts in RNA samples from frozen tissue from the tumor. The final diagnosis was primary pulmonary biphasic synovial sarcoma.

DISCUSSION
Synovial sarcoma is a rare mesenchymal tumor, accounting for only 10% of all soft tissue tumors [3,4]. It commonly occurs in soft tissue in the extremities in adolescents and young adults. However other sites including lung, mediastinum, heart, head and neck have been reported [5][6][7].
Primary synovial sarcoma of the lung is rare and accounts for less than 0.5% of all lung tumors [1]. It was described in 1995 by Zeren et al. as a distinctive primary sarcoma of the lung that nevertheless shared histological and immunohistochemical features with synovial sarcoma [8].
More than half of primary synovial sarcomas of the lung are centrally located and associated with obstructive   pneumonia, atelectasis, and hemoptysis [9][10][11][12][13]. Peripheral tumors such as that described here are less common and usually asymptomatic. The tumor in the present case was also asymptomatic, although it had rapidly enlarged in a short period after CT-guided needle biopsy.
Primary synovial sarcomas of the lung fall into four subtypes: monophasic fibrous, monophasic epithelial, biphasic, and poorly differentiated. The monophasic subtype is the most common [14]. Although a diagnosis of biphasic synovial sarcoma is usually easy, focal well-formed papillary or adenomatoid areas may be interpreted as carcinomas or malignant mesotheliomas. In particular, pleomorphic carcinomas can present with spindle cell and adenocarcinoma components [12]. Carcinomas are more cytologically atypical and have greater pleomorphism than primary synovial sarcomas of the lung. Synovial sarcoma is characterized by a reciprocal chromosomal translocation (X; 18) (p11.2; q11.2) that results from fusion of the SYT gene on chromosome 18 to one of two genes, (SSX1 and SSX2) on chromosome X [15][16][17][18]. Therefore, cytogenetic studies using reverse transcriptase-polymerase chain reaction are useful for difficult-to-diagnosis cases. In our case, the first tentative pathological diagnosis was pleomorphic carcinoma. After verifying the presence of SYT-SSX fusion gene transcripts, the final diagnosis was revised primary synovial sarcoma of the lung.
The therapy of choice in cases such as that presented here is surgical removal of the tumor with the aim of achieving negative resection margins. Complete surgical resection, and not the size or grade of the tumor is significantly associated with increased survival [19]. However, prognosis is poor in such cases. The effects of adjuvant chemoradiotherapy are unclear, as it has not been tested in randomized trials. Although complete removal of the tumor was successfully performed in the case presented here, the patient died due to the local recurrence of the tumor within one year after sugery.

CONCLUSION
Primary synovial sarcoma of the lung is an extremely rare and aggressive tumor with poor prognosis. It should be diagnosed using radiology, histology, immunohistochemistry, and molecular techniques. The most appropriate management for this condition is surgical excision with negative margins, although the prognosis is limited.

Author Contributions
Hiroshi Hashimoto -Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Yuichi Ozeki -Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Koji Kameda -Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Hideyuki Shimazaki -Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Kuniaki Nakanishi -Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Shinichi Taguchi -Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published